GLP-1 drugs linked to nutritional deficiencies in 1 in 6 children

A study in Childhood Obesity found that 16.8% of children aged 10–17 starting GLP-1 therapy were diagnosed with a nutritional deficiency within the first year, most often vitamin D (12.4%). Only 5% received nutritional counseling within 30 days of starting treatment.

• 16.8% of children on GLP-1s were diagnosed with a nutritional deficiency within a year
• Vitamin D deficiency affected 12.4% of children within one year of starting therapy
• Liraglutide accounted for 78.6% of prescriptions, dulaglutide 10.4%, semaglutide 9.1%
• Only 5% received nutritional counseling within 30 days of treatment